BioCentury
ARTICLE | Company News

Kythera, Allergan deal

June 22, 2015 7:00 AM UTC

Allergan will acquire Kythera for about $2.1 billion in a cash and stock deal. Kythera shareholders will receive $60 per share in cash plus $15 per share in Allergan common shares. The $75 per share total is a 24% premium to Kythera’s close of $60.72 on June 16, the day before the deal was announced. ...